Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-08-19 00:00:00 ET · period of report 2022-07-01 · accession 0001209191-22-046896 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-08-19	2022-07-01+	CPIX	Galante Joseph C	Dir	P - Purchase	$2.31	+2,125	50.9K	+4%	+$4,912

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-07-01	P	A	70	$2.11	48,836	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
2	Common	Common Stock	2022-07-05	P	A	86	$2.18	48,922	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
3	Common	Common Stock	2022-07-06	P	A	86	$2.11	49,008	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
4	Common	Common Stock	2022-07-07	P	A	86	$2.18	49,094	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
5	Common	Common Stock	2022-07-08	P	A	86	$2.19	49,180	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
6	Common	Common Stock	2022-07-12	P	A	86	$2.25	49,266	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
7	Common	Common Stock	2022-07-14	P	A	86	$2.28	49,352	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
8	Common	Common Stock	2022-07-15	P	A	86	$2.23	49,438	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
9	Common	Common Stock	2022-07-18	P	A	74	$2.41	49,512	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
10	Common	Common Stock	2022-07-19	P	A	74	$2.47	49,586	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
11	Common	Common Stock	2022-07-20	P	A	74	$2.52	49,660	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
12	Common	Common Stock	2022-07-21	P	A	74	$2.54	49,734	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
13	Common	Common Stock	2022-07-22	P	A	74	$2.53	49,808	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
14	Common	Common Stock	2022-07-25	P	A	74	$2.48	49,882	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
15	Common	Common Stock	2022-07-26	P	A	74	$2.47	49,956	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
16	Common	Common Stock	2022-07-27	P	A	60	$2.36	50,016	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
17	Common	Common Stock	2022-07-28	P	A	74	$2.28	50,090	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
18	Common	Common Stock	2022-07-29	P	A	74	$2.28	50,164	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
19	Common	Common Stock	2022-08-01	P	A	74	$2.34	50,238	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
20	Common	Common Stock	2022-08-03	P	A	30	$2.45	50,268	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
21	Common	Common Stock	2022-08-04	P	A	74	$2.17	50,342	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
22	Common	Common Stock	2022-08-05	P	A	74	$2.12	50,416	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
23	Common	Common Stock	2022-08-08	P	A	82	$2.19	50,498	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
24	Common	Common Stock	2022-08-09	P	A	82	$2.19	50,580	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
25	Common	Common Stock	2022-08-10	P	A	82	$2.19	50,662	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
26	Common	Common Stock	2022-08-11	P	A	82	$2.46	50,744	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
27	Common	Common Stock	2022-08-12	P	A	82	$2.52	50,826	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
28	Common	Common Stock	2022-08-15	P	A	65	$2.45	50,891	D	—	—	(F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.